What German experts expect from individualized medicine: Problems of uncertainty and future complication in physician-patient interaction

Clinical Ethics

Volumn 7, Issue 2, 2012, Pages 86-93

  Heßling, Arndt ^a   Schicktanz, Silke ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864222902     PISSN: 14777509     EISSN: 1758101X     Source Type: Journal    
DOI: 10.1258/ce.2012.12-001     Document Type: Article

References (40)

1. Hayes DF. Contribution of biomarkers to personalized medicine. Breast Cancer Res 2010;12(Suppl. 4)
2. Husing B. [Individualised medicine-potentials and need for action]. Z Evid Fortbild Qual Gesundhwes 2010;104:727-31
3. Simon R. Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology. Personal Med 2010;7:33-47
4. Hildt E. Predictive genetic testing, autonomy and responsibility for future health. Med Stud 2009;1:143-53
5. Bhasker CR, Hardiman G. Advances in pharmacogenomics technologies. Pharmacogenomics 2010;11:481-5
6. Van Aken J, Schmedders M, Feuerstein G, Kollek R. Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience. Am J Pharmacogenomics 2003;3:149-55
7. Hopkins MM, Ibarreta D, Gaisser S, et al. Putting pharmacogenetics into practice. Nat Biotechnol 2006;24:403-10
8. Ghadimi BM, Grade M, Difilippantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005;23:1826-38
9. Li X, Quigg RJ, Zhou J, Gu W, Nagesh Rao P, Reed EF. Clinical utility of microarrays: current status, existing challenges and future outlook. Curr Genomics 2008;9:466-74
10. Van't Veer LJ, Bernards R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008;452:564-70
11. Liggett SB. Pharmacogenetic applications of the Human Genome project. Nat Med 2001;7:281-3
12. Schmedders M, Van Aken J, Feuerstein G, Kollek R. Individualized pharmacogenetic therapy: a critical analysis. Community Genet 2003;6:114-9
13. Nelkin D. Promotional metaphors and their popular appeal. Public Underst Sci 1994;3:25-31
14. Dowsett SM, Saul JL, Butow PN, et al. Communication styles in the cancer consultation: preferences for a patient-centred approach. Psychooncology 2000;9:147-56
15. Rippe KP, Bachmann A, Faisst K, et al. Pharmakogenetik und Pharmakogenomik. Bern: Zentrum für Technologiefolgeabschätzung, 2004
16. Hedgecoe A. Context, ethics and pharmacogenetics. Stud Hist Philos Biol Biomed Sci 2006;37:566-82
17. Wittner BS, Sgroi DC, Ryan PD, et al. Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res 2008;14:2988-93
18. Rogausch A, Prause D, Schallenberg A, Brockmöller J, Himmel W. Patients' and physicians' perspectives on pharmacogenetic testing. Future Med 2006;7:49-59
19. Barnoy S. Genetic testing for late-onset diseases: effect of disease controllability, test predictivity, and gender on the decision to take the test. Genetic Test 2007;11:187-92
20. Hallowell N, Cooke S, Crawford G, Parker M, Lucasson A. Healthcare professionals' and researchers' understanding of cancer genetics activities: a qualitative interview study. J Med Ethics 2008;35:113-9
21. Bister M. 'Jemand kommt zu Dir und sagt bitte': Eine empirische Studie zur Gewebespende im Krankenhauskontext. O ̈ ZS 2009;34:72-8
22. Corrigan O. Empty ethics: the problem with informed consent. Sociol Health Illn 2003;25:768-92
23. Hedgecoe A. 'At the point at which you can do something about it, then it becomes more relevant': informed consent in the pharmacogenetic clinic. Soc Sci Med 2005;61:1201-10
24. Schmiegel W, Pox C, Reinacher-Schick A, et al. S3-Leitlinie 'Kolorektales Karzinom' Ergebnisse evidenzbasierter Konsensuskonferenzen am 6./7. Februar 2004 und am 8./9. Juni 2007 (fü r die Themenkomplexe IV, VI und VII) S3-Guideline 'Colorectal Cancer' 2004/2008. Z Gastroenterol 2008;46:1-73
25. Kowal S, O'connell DC. Zur Transkription von Gesprächen. In: Flick U, Kardoff EV, Steinke I, eds. Qualitative Forschung. Reinbeck bei Hamburg: Rowohlt Taschenbuch Verlag, 2003
26. Mayring P. Qualitative Content Analysis. Forum: Qualitative Social Research. Weinheim: Beltz Verlag, 2007
27. Chandros Hull S, Taylor H, Kass N. Qualitative Methods. In: Sugarman J, Sulmasy D, eds. Methods in Medical Ethics. Washington DC: Georgetown University Press, 2001
28. Altman D, Bland JM. Diagnostic tests 2: predictive values. BMJ 1994;309:102
29. Schneider A, Löwe B, Barie S, Joos S, Engeser P, Szecsenyi J. How do primary care doctors deal with uncertainty in making diagnostic decisions? The development of the 'Dealing with Uncertainty Questionnaire'. J Eval Clin Pract 2010;16:431-7
30. Marx-Stölting L. Pharmakogenetik und Pharmakogentests Biologische, wissenschaftstheoretische und ethische Aspekte des Umgangs mit genetischen Variationen. Berlin: LIT Verlag, 2007
31. Gigerenzer G, Muir Gray JA. Better Doctors, Better Patients, Better Decisions. Envisioning Health Care 2020. Cambridge, MA: MIT Press, 2011
32. Fuller R. Managing health risks: junior doctors' views of risk and decision making. J Health Organ Manag 2004;18:155-78
33. Loh A, Simon D, Bieber C, Eich W, Härter M. Patient and citizen participation in German health care-current state and future perspectives. Z Arztl Fortbild Qual Gesundh wes 2007:229-35
34. Gattellari M, Butow PN, Tattersall MH, Dunn SM, Macleod CA. Misunderstanding in cancer patients: why shoot the messenger?. Ann Oncol 1999;10:39-46
35. Vodermaier A, Caspari C, Wang L, Koehm J, Ditsch N, Untch M. How and for whom are decision aids effective? Long-term psychological outcome of a randomized controlled trial in women with newly diagnosed breast cancer. Health Psychol 2011;30:12-9
36. Beskow LM, Burke W. Offering individual genetic research results: context matters. Sci Transl Med 2010;2:38
37. Mccarty CA, Garber A, Reeser JC, Fost NC. Study newsletters, community and ethics advisory boards, and focus group discussions provide ongoing feedback for a large biobank. Am J Med Genet A 2011;155A:737-41
38. Nuffield Council on Bioethics. Pharmacogenetics Ethical Issues. London: Nuffield Council on Bioethics, 2003
39. Nuffield Council on Bioethics. Medical Profiling and Online Medicine: the Ethics of 'Personalised Healthcare' in a Consumer Age. London: Nuffield Council on Bioethics, 2010
40. Bottles K. A revolution in genetics: changing medicine, changing lives. Physician Exec 2001;27:58-63